CoChat

Calcineurin Inhibitors and the IL12A Locus Influence Risk of Recurrent Primary Biliary Cirrhosis After Liver Transplantation

Open access
Carbone, M., Mells, G.F., Alexander, G.J., Westbrook, R.H., Heneghan, M.A., Sandford, R.N., Neuberger, J.M. · 2013 · American Journal of Transplantation
Cited by 49

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

To the Editor: Genomewide association studies and Illumina immunoarray (iCHIP) association studies of primary biliary cirrhosis (PBC) have identified 29 genetic loci associated with disease. We hypothesized that risk loci for PBC in the native liver might influence the risk of PBC recurring after liver transplantation (LT). To address this hypothesis, we analyzed 248 PBC LT recipients for whom genotype data were available from the Wellcome Trust Case-Control Consortium (WTCCC3) iCHIP association study of PBC (1Liu JZ Almarri MA Gaffney DJ et al.Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis.Nat Genet. 2012; 44: 1137-1141Crossref PubMed Scopus (210) Google Scholar). Recurrent PBC (rPBC) was defined as a liver allograft biopsy (protocol or event) showing at least two of the following abnormalities in the portal tracts: lymphocytic cell infiltrate, lymphoid aggregates, granulomas or bile duct lesions. One hundred and five (42.3%) LT recipients developed rPBC (median time to recurrence: 61.8 months; 25–75%, IQR: 16.7–103.8). On univariate analysis the following variables influenced the risk of rPBC: calcineurin-inhibitor (CNI) selection at induction (Cyclosporin vs. Tacrolimus: hazard ratio [HR] = 0.47, p = 0.001); CNI selection at 1-year (HR = 0.40, p = 9.8×10−5), the SNPs rs62270414 (HR = 1.4, p = 0.04) and rs668998 (HR = 0.68, p = 0.015) at 3q25 (IL12A locus), and the SNP rs11117433 (HR = 0.6, p = 0.045) at 16q24 (IRF8 locus). In multivariate analysis using the Cox model, only CNI selection at 1-year and rs62270414 were significant. The final model consisted of CNI selection at 1-year (HR = 2.77, 95% CI 1.6–5.0, p = 2.7×10−5) and rs62270414 (risk allele G, HR = 1.65, 95% CI 1.1–2.4, p = 0.008) (Figure 1). We report for the first time the association of rPBC with the IL12A locus. This observation is highly plausible given the strong association between variants at the IL12A locus and susceptibility to PBC in native liver (2Hirschfield GM Liu X Xu C et al.Primary biliary cirrhosis associated with HLA. IL12A. and IL12RB2 variants.N Engl J Med. 2009; 360: 2544-2555Crossref PubMed Scopus (512) Google Scholar, 3Liu X Invernizzi P Lu Y et al.Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis.Nat Genet. 2010; 42: 658-660Crossref PubMed Scopus (335) Google Scholar, 4Mells GF Floyd JA Morley KI et al.Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis.Nat Genet. 2011; 43: 329-332Crossref PubMed Scopus (389) Google Scholar). A major effect of IL-12 signaling is TH1 polarization of the acquired immune response. In PBC, variation in IL-12 signaling may lead to inappropriate and sustained TH1 responses. Alternatively, variation in IL-12 signaling may lead to inefficient TH1 responses to appropriate stimuli. It is plausible that either mechanism could lead to disease: PBC in the native liver as well as rPBC in the liver allograft. The association between rPBC and choice of CNI has been previously described (5Silveira MG Talwalkar JA Lindor KD et al.Recurrent primary biliary cirrhosis after liver transplantation.Am J Transplant. 2010; 10: 720-726Abstract Full Text Full Text PDF PubMed Scopus (64) Google Scholar). Tacrolimus and Cyclosporin use different mechanisms to block expression of interleukin-2 (IL-2), which influences IL-12-dependent IFN-gamma production and has a critical role in the regulation of growth, differentiation and survival of activated T cells. It is unclear how IL-2 inhibition or the interaction of IL-2 and IL-12 signaling pathways might influence disease recurrence. This study has notable weaknesses. In particular, the study was underpowered to identify the modest effects of common genetic variants, compounded by a poorly defined phenotype. Nevertheless, finding association at the IL12A locus suggests that mechanisms causing PBC in the allograft might be similar to those causing PBC in the native liver. Hence, LT may provide a unique setting to examine the pathophysiology of PBC. Using protocol biopsies to pinpoint the onset of disease, it might be possible to elucidate the innate and adaptive immune processes active at the earliest stage of disease. We therefore believe that the substantial effort required for better-powered genetic and translational studies of rPBC are justified. We gratefully acknowledge the UK PBC Consortium and the Wellcome Trust Case Control Consortium for granting access to the UK PBC database of the WTCCC3 iCHIP Study of PBC. Marco Carbone was supported by a Short-term Sheila Sherlock Fellowship from EASL. The authors of this manuscript have no conflicts of interest to disclose as described by the American Journal of Transplantation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/ajt.12132

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 49

Metadata

Authors
Carbone, M., Mells, G. F., Alexander, G. J., Westbrook, R. H., Heneghan, M. A., Sandford, R. N., & Neuberger, J. M.
Venue
American Journal of Transplantation
Publisher
Elsevier BV
Published
2013-04
Volume
13
Issue
4
Pages
1110-1111
ISSN
1600-6135 (ISSN-L)
OpenAlex
W2040959818
Cited by
49
References
4
FWCI
2.57
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.